Association of the C-344T aldosterone synthase gene variant with essential hypertension: A meta-analysis

Journal of Hypertension

Volumn 25, Issue 1, 2007, Pages 5-13

  Sookoian, Silvia ^a   Gianotti, Tomas Fernández ^a   González, Claudio Daniel ^b   Pirola, Carlos Jose ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aldosterone; Aldosterone synthase; CS344T; CYP11B2 gene; Genetics; Hypertension; Meta analysis; Plasma renin activity; Polymorphism

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE;

AFRICA; AFRICAN AMERICAN; ALDOSTERONE BLOOD LEVEL; ALLELE; CAUCASIAN; CHINESE; CLINICAL TRIAL; COHORT ANALYSIS; CYP11B2 GENE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; ETHNOLOGY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HISPANIC; HOMOZYGOTE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; META ANALYSIS; PHENOTYPE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 33845355513     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000254372.88488.a9     Document Type: Review

References (62)

1. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994; 331:250-258.
2. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res 1995; 21:437-442.
3. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE. Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 2002; 28:125-135.
4. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32:198-204.
5. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33:703-707.
6. Casiglia E, Tikhonoff V, Mazza A, Rynkiewicz A, Limon J, Caffi S, et al. C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens 2005; 23:1991-1996.
7. Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H, et al. Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens 2002; 16:789-793.
8. Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens 2003; 21:1331-1337.
9. Tamaki S, Iwai N, Tsujita Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 1999; 33:266-270.
10. Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T, et al. Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 2000; 18:1025-1032.
11. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11:856-860.
12. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 1999; 99:2255-2260.
13. Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res 2001; 24:105-109.
14. Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens 2004; 22:1895-1901.
15. Kosachunhanun N, Hunt SC, Hopkins PN, Williams RR, Jeunemaitre X, Corvol P, et al. Genetic determinants of nonmodulating hypertension. Hypertension 2003; 42:901-908.
16. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, et al. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Am J Hypertens 2002; 15:389-393.
17. Lim PO, Macdonald TM, Holloway C, Friel E, Anderson NH, Dow E, et al. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 2002; 87:4398-4402.
18. Stolarz K, Staessen JA, Kawecka-Jaszcz K, Brand E, Bianchi G, Kuznetsova T, et al. Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretion. Hypertension 2004; 44:156-162.
19. Tang W, Devereux RB, Rao DC, Oberman A, Hopkins PN, Kitzman DW, Arnett DK. Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study. Am Heart J 2002; 143:854-860.
20. Pamies-Andreu E, Ramirez-Lorca R, Stiefel GJ, Muniz-Grijalbo O, Vallejo-Maroto I, Garcia MS, et al. Renin-angiotensin-aldosterone system and G-protein beta-3 subunit gene polymorphisms in salt-sensitive essential hypertension. J Hum Hypertens 2003; 17:187-191.
21. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A de LS. Molecular basis of salt sensitivity in human hypertension Evaluation of renin-angiotensin- aldosterone system gene polymorphisms. Hypertension 2001; 38:1204-1209.
22. Matsubara M, Sato T, Nishimura T, Suzuki M, Kikuya M, Metoki H, et al. CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama study. Hypertens Res 2004; 27:1-6.
23. Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P. A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 2003; 88:2495-2500.
24. Isaji M, Mune T, Takada N, Yamamoto Y, Suwa T, Morita H, et al. Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2. J Hypertens 2005; 23:1149-1157.
25. Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev 1992; 14:154-176.
26. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, et al. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf) 2004; 61:174-181.
27. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33:177-182.
28. Brand E, Schorr U, Ringel J, Beige J, Distler A, Sharma AM. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST). J Hypertens 1999; 17:1563-1567.
29. Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, et al. Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens 2003; 21:1853-1860.
30. Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V, Schmieder RE. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 2001; 37:878-884.
31. Gu D, Ge D, He J, Li B, Chen J, Liu D, et al. Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese. Clin Genet 2004; 66:409-416.
32. Henderson SO, Haiman CA, Mack W. Multiple polymorphisms in the renin- angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am J Med Sci 2004; 328:266-273.
33. Hengstenberg C, Holmer SR, Mayer B, Lowel H, Engel S, Hense HW, et al. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 2000; 35:704-709.
34. Kathiresan S, Larson MG, Benjamin EJ, Corey D, Murabito JM, Fox CS, et al. Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens 2005; 18:657-665.
35. Kikuya M, Sugimoto K, Katsuya T, Suzuki M, Sato T, Funahashi J, et al. A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study. Hypertens Res 2003; 26:141-145.
36. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998; 97:569-575.
37. Matsubara M, Kikuya M, Ohkubo T, Metoki H, Omori F, Fujiwara T, et al. Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. J Hypertens 2001; 19:2179-2184.
38. Porto PI, Garcia SI, Dieuzeide G, Gonzalez C, Pirola CJ. Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension. Clin Exp Hypertens 2003; 25:117-130.
39. Rajput C, Makhijani K, Norboo T, Afrin F, Sharma M, Pasha ST, Pasha MA. CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake. J Hypertens 2005; 23:79-86.
40. Russo P, Siani A, Venezia A, Iacone R, Russo O, Barba G, et al. Interaction between the C(-344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 2002; 20:1785-1792.
41. Sarzani R, Salvi F, Dessi-Fulgheri P, Catalini R, Mazzara D, Cola G, et al. Aldosterone synthase alleles and cardiovascular phenotype in young adults. J Hum Hypertens 2003; 17:859-864.
42. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19:1349-1358.
43. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, et al. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 2004; 22:937-944.
44. Wojciechowska W, Staessen JA, Stolarz K, Nawrot T, Filipovsky J, Ticha M, et al. Association of peripheral and central arterial wave reflections with the CYP11B2 -344C allele and sodium excretion. J Hypertens 2004; 22:2311-2319.
45. Zhu H, Sagnella GA, Dong Y, Miller MA, Onipinla A, Markandu ND, MacGregor GA. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens 2003; 21:87-95.
46. Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, et al. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) 2001; 54:813-817.
47. Hautanena A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H, White PC. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med 1998; 244:11-18.
48. Heller S, Linhart A, Jindra A, Jachymova M, Horky K, Peleska J, et al. Association of -344/T/C aldosterone synthase polymorphism (CYP11B2) with left ventricular structure and humoral parameters in young normotensive men. Blood Press 2004; 13:158-163.
49. Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Nishimori T, Takasu N. Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 2000; 35:699-703.
50. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, et al. Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001; 19:407-413.
51. Mulatero P, Williams TA, Milan A, Paglieri C, Rabbia F, Fallo F, Veglio F. Blood pressure in patients with primary aldosteronism is influenced by bradykinin B(2) receptor and alpha-adducin gene polymorphisms. J Clin Endocrinol Metab 2002; 87:3337-3343.
52. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34:423-429.
53. Patel R, Lim DS, Reddy D, Nagueh SF, Lutucuta S, Sole MJ, et al. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32:2369-2377.
54. Rossi E, Regolisti G, Perazzoli F, Negro A, Davoli S, Nicoli D, et al. -344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension. Am J Hypertens 2001; 14:934-941.
55. Stella P, Bigatti G, Tizzoni L, Barlassina C, Lanzani C, Bianchi G, Cusi D. Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J Am Coll Cardiol 2004; 43:265-270.
56. Safar ME, Cattan V, Lacolley P, Nzietchueng R, Labat C, Lajemi M, et al. Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension. J Hypertens 2005; 23:1159-1166.
57. Patel S, Steeds R, Channer K, Samani NJ. Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction. Am J Hypertens 2000; 13:134-139.
58. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361:567-571.
59. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367:651-658.
60. Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, et al. A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005; 162:302-304.
61. Drayer JI, Weber MA, Laragh JH, Sealey JE. Renin subgroups in essential hypertension. Clin Exp Hypertens A 1982; 4:1817-1834.
62. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004; 36:1312-1318.